Confluent (CFLT) CFO reports 8,000-share sale and holds 591,738 shares

Q: What insider transaction did Confluent (CFLT) disclose in this Form 4?

The chief financial officer of Confluent, Inc. reported selling 8,000 shares of Class A common stock on 12/01/2025 .

Q: At what price did the Confluent (CFLT) CFO sell shares?

The CFO’s 8,000 shares of Class A common stock were sold at prices ranging from $21.71 to $22.63 .

Q: Was the Confluent (CFLT) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the 8,000-share sale was made pursuant to a Rule 10b5-1 trading plan dated September 12, 2024 .

Q: What is the role of the reporting person in Confluent (CFLT)?

The reporting person in this Form 4 is an officer of Confluent, Inc., serving as the company’s chief financial officer .

Q: Is this Confluent (CFLT) Form 4 filed by more than one reporting person?

No. The document indicates it is a Form filed by one reporting person , not a joint filing.

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Confluent, Inc.'s chief financial officer reported a planned stock sale under a Rule 10b5-1 trading plan. On 12/01/2025, the executive sold 8,000 shares of Class A common stock at prices ranging from $21.71 to $22.63 as part of a pre-arranged plan dated September 12, 2024. After this transaction, the officer beneficially owns 591,738 shares of Confluent Class A common stock.

Insider Trade Summary

Net Seller: 8,000 shares

Net Sell 1 txn

Insider Sivaram Rohan

Role CHIEF FINANCIAL OFFICER

Sold 8,000 shs ($177K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	8,000	$22.12	$177K

Holdings After Transaction: Class A Common Stock — 591,738 shares (Direct)

Footnotes (2)

F1. Shares sold pursuant to a 10b5-1 trading plan dated September 12, 2024.
F2. The shares were sold at prices ranging from $21.71 to $22.63. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

FAQ

What insider transaction did Confluent (CFLT) disclose in this Form 4?

The chief financial officer of Confluent, Inc. reported selling 8,000 shares of Class A common stock on 12/01/2025.

At what price did the Confluent (CFLT) CFO sell shares?

The CFO’s 8,000 shares of Class A common stock were sold at prices ranging from $21.71 to $22.63.

How many Confluent (CFLT) shares does the CFO still own after the sale?

Following the reported transaction, the Confluent CFO beneficially owns 591,738 shares of Class A common stock.

Was the Confluent (CFLT) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the 8,000-share sale was made pursuant to a Rule 10b5-1 trading plan dated September 12, 2024.

What is the role of the reporting person in Confluent (CFLT)?

The reporting person in this Form 4 is an officer of Confluent, Inc., serving as the company’s chief financial officer.

Is this Confluent (CFLT) Form 4 filed by more than one reporting person?

No. The document indicates it is a Form filed by one reporting person, not a joint filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/03/2025 - 06:39 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sivaram Rohan

(Last)

(First)

(Middle)

C/O CONFLUENT, INC.

899 W. EVELYN AVENUE

(Street)

MOUNTAIN VIEW

94041

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Confluent, Inc. [ CFLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CHIEF FINANCIAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	12/01/2025		S		8,000⁽¹⁾	D	$22.12⁽²⁾	591,738	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares sold pursuant to a 10b5-1 trading plan dated September 12, 2024.

2. The shares were sold at prices ranging from $21.71 to $22.63. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Weilyn Wood, Attorney-in-Fact	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR